Stocks · Health care · Pharmaceutical Preparations

CORCEPT THERAPEUTICS INC

CORT Clue Score67
United States Fiscal year ends December CIK 0001088856 Results filed 3 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Gary Charles Robb
17 Aug 2026
Chief Business Officer
Sell indirect
10,000
$116.26
$1.16M
Joseph Douglas Lyon
3 Aug 2026
See Remarks
Sell
1,540
$114.16
$175.81K
David L Mahoney
17 Jun 2026
Director
Sell indirect
20,000
$84.53
$1.69M
Joseph Douglas Lyon
27 May 2026
See Remarks
Sell
5,000
$65.00
$325.00K
William Guyer
25 Nov 2025
Chief Development Officer
Sell
4,500
$80.90
$364.07K
Gary Charles Robb
16 Jun 2025
Chief Business Officer
Sell
3,185
$70.77
$225.40K
Gary Charles Robb
20 May 2025
Chief Business Officer
Sell
2,279
$75.85
$172.86K
Joseph Douglas Lyon
22 Nov 2024
See Remarks
Sell
1,411
$56.72
$80.03K
Gary Charles Robb
22 Nov 2024
Chief Business Officer
Sell
2,609
$56.20
$146.63K
Gary Charles Robb
26 Aug 2024
Chief Business Officer
Sell
3,101
$35.71
$110.74K
Showing 250 of 501 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 533
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 54
Sales straight out of an exercise 272
Sales at will 81
Transactions with no price 0
Shares from compensation/vesting 26,054,175
Sales filed before the plan box existed 65
History held since 3 Oct 2006